SCHEMBL9943582

SCHEMBL9943582

Cn1c(=O)c2[nH]c(-n3cc(C4CCCCC4N)nn3)nc2n(C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 5/20 0.46
ADORA2A P29274 4/20 0.46
MAPK1 P28482 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALOX15 P16050 1/20 0.42
HIF1A Q16665 1/20 0.42
DCTPP1 Q9H773 2/20 0.41
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.38
ADORA1 P30542 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CASP1 P29466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928555 0.85 ADORA2A (0.58) ADORA2BADORA2AMAPK1ADORA3MEN1
SCHEMBL9928558 0.71 ADORA2A (0.43) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9928559 0.70 KDM4E (0.49) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9904126 0.70 DCTPP1 (0.56) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9904211 0.69 MEN1 (0.44) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9904070 0.69 ALDH1A1 (0.51) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9928563 0.69 GAA (0.56) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9943454 0.69 ALDH1A1 (0.64) ADORA2BADORA2AADORA3MEN1KMT2A
SCHEMBL9928556 0.69 ADORA2B (0.61) ADORA2BADORA2ACYP1A2CYP3A4GAA
SCHEMBL9904107 0.68 ADORA2B (0.46) ADORA2BADORA2AADORA3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed